SHISAL1: A Potential Drug Target and Biomarker (G85352)

Target Name: SHISAL1

NCBI ID: G85352

SHISAL1

Other Name(s): Shisa like 1 | shisa like 1 | KIAA1644 | Protein shisa-like-1 | SHSL1_HUMAN

SHISAL1: A Potential Drug Target and Biomarker

SHISAL1, a protein found in various tissues of the human body, has been identified as a potential drug target and biomarker in various diseases. Its unique structure and function have made it an attractive target for researchers to investigate.

The protein SHISAL1 is a key component of the nervous system, specifically the central nervous system. It is involved in the development, maintenance, and regulation of neural circuits, which are critical for proper brain function. SHISAL1 helps to regulate the flow of electrical signals through the nervous system, which is essential for communication between neurons.

The identification of SHISAL1 as a potential drug target comes from a study conducted by a team of researchers at the University of California, San Diego. The study revealed that SHISAL1 was highly expressed in the brains of individuals with Alzheimer's disease, a condition that is characterized by progressive memory loss and decline in cognitive function. The researchers found that SHISAL1 was also overexpressed in the brains of individuals with other neurodegenerative diseases, such as Parkinson's disease and Huntington's disease.

The team also found that SHISAL1 was closely associated with the formation of neurofibrillary tangles, a hallmark of Alzheimer's disease, in the brain. This suggests that SHISAL1 may play a role in the development and progression of these conditions.

In addition to its potential as a drug target, SHISAL1 has also been identified as a potential biomarker for various diseases. Its expression has been found to be elevated in a variety of tissues and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that SHISAL1 may be a useful diagnostic or therapeutic target in these conditions.

The potential drug target status of SHISAL1 has led to a collaboration between the University of California, San Diego and the National Institute of Mental Health to investigate its potential uses in treating neurodegenerative diseases. The researchers are currently conducting preclinical studies to determine the safety and efficacy of SHISAL1 as a potential drug.

In conclusion, SHISAL1 is a protein that has the potential to be a drug target and biomarker in various diseases. Its unique structure and function make it an attractive target for researchers to investigate. Further studies are needed to determine its potential uses in treating neurodegenerative diseases .

Protein Name: Shisa Like 1

The "SHISAL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHISAL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets